Company Filing History:
Years Active: 2025
Title: Zhenming An: Innovator in Antibody Research
Introduction
Zhenming An is a prominent inventor based in Shandong, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of 2 patents, his work is recognized for its potential impact on medical science.
Latest Patents
Zhenming An's latest patents include an "Antibody against claudin 18A2 and use thereof." This patent provides an anti-CLDN18.2 antibody or an antigen-binding fragment, along with a pharmaceutical composition for treating, diagnosing, and detecting cancers. Another notable patent is for a "Composition comprising aflibercept and a variant thereof, and related methods and uses." This patent describes a composition that includes aflibercept and a truncation variant, which is crucial for quality inspection of aflibercept-containing products.
Career Highlights
Zhenming An is currently associated with Qilu Pharmaceutical Co., Ltd., where he continues to advance his research in antibody development. His work is instrumental in creating innovative solutions for cancer treatment, showcasing his dedication to improving healthcare outcomes.
Collaborations
Zhenming An collaborates with esteemed colleagues such as Yue Yu and Guijiang Wang. Their combined expertise fosters a productive research environment, enhancing the potential for groundbreaking discoveries in the field.
Conclusion
Zhenming An's contributions to antibody research and his innovative patents position him as a key figure in the biotechnology industry. His work not only advances scientific knowledge but also holds promise for future medical applications.